Morgan J, Neufeld SD, Holroyd H, Ruiz J, Taylor T, Nolan S, Glegg S Community-Engaged Research Ethics Training (CERET): developing accessible and relevant research ethics training for community-based participatory research with people with lived and living experience using illicit drugs and harm reduction workers Harm Reduct J, 2023. PubMed

Mocanu V, Bozinoff N, Wood E, Jutras-Aswad D, Le Foll B, Lim R, Choi JC, Mok WY, Socías ME; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse Opioid agonist therapy switching among individuals with prescription-type opioid use disorder: secondary analysis of a pragmatic randomized trial Drug Alcohol Depend, 2023. PubMed

Mayer S, Boyd J, Fairbairn N, Chapman J, Brohman I, Jenkins E, McNeil R Women's experiences in injectable opioid agonist treatment programs in Vancouver, Canada Int J Drug Policy, 2023. PubMed

Brooks O, Ng JCY, Ickowicz S Outpatient rapid titration of slow release oral morphine for the treatment of opioid use disorder in a Canadian setting: a case series J Addict Med, 2023. PubMed

El-Akkad S, Nolan S, Hayashi K, Dong H, Milloy MJ, DeBeck K, Ti L Factors associated with patient perceived suboptimal dosing of in-hospital opioid agonist therapy among people who use illicit drugs in Vancouver, Canada J Addict Dis, 2023. PubMed

Javanbakht M, Khan L, Mustanski B, Shoptaw S, Baum MK, Mehta SH, Kirk GD, Lai S, Moore R, Milloy MJ, Kipke M, Hayashi K, DeBeck K, Siminski S, White LM, Gorbach P Substance use and other factors associated with COVID-19 vaccine uptake among people at risk for or living with HIV: findings from the C3PNO Consortium Prev Med Rep, 2023. Link

Argento E, Omene E, Jaeger AH, Kertes A, Mitchell KA, Necyk C, Thielking P, Lewis EC Case report: Improvement in refractory functional seizures, depression, and quality of life with ketamine-assisted therapy Front Neurosci, 2023. PubMed

Capler NR, Balneaves LG, Buxton JA, Kerr T Reasonable access: important characteristics and perceived quality of legal and illegal sources of cannabis for medical purposes in Canada J Cannabis Res, 2023. PubMed

Weaver VK, Ickowicz S, Fairbairn N Management of γ-hydroxybutyrate intoxication and withdrawal CMAJ, 2023. PubMed

van Santen DK, Lodi S, Dietze P, van den Boom W, Hayashi K, Dong H, Cui Z, Maher L, Hickman M, Boyd A, Prins M Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: a pooled analysis of emulated trials Addiction, 2023. PubMed

Filter Publications

  • Year

    -
  • Reset filter